Our Partners

Third largest healthcare company in the world, based in Switzerland. The company specializes in diagnostics and pharmaceuticals, with dominance in cancer treatments. Over thirty medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines.
Roche has worked with dHealth team on three different use cases: treatment monitoring, blockchain-based COVID antibody certificates, and blockchain-based Digital Identity Solution where stakeholders' credentials can be managed and verified to prevent errors and fraud. Roche is also actively maintaining a dHealth’s network Validator Node.
Read More
OrganX is a non-profit health Organization (NPHO) that was established in Switzerland to exponentially accelerate advances in Organ Technologies and patients' access to organ health. OrganX’s mission is to modernize medicine by enhancing medical guidelines and public health policies, and also to support the world's leading institutions to help them accelerate their research. Likewise, OrganX Foundation works tirelessly on supporting early technologies that have great potential but are not currently ready for deployment on the market.
dHealth partnered with the OrganX Foundation to build the first AI-powered and blockchain-powered solid organ exchange. The exchange will be operated on a nonprofit basis and will align the incentives of all stakeholders along the transplantation continuum by making its processes more effective, efficient, transparent, secure, and trustworthy. In more concrete terms, the result of the partnership will be the creation of a fully virtualized and tokenized transplant ecosystem with trust at its core. Ultimately, it is the goal of the partnership to optimize the matching between donor organs and the potential recipients, hence, improving the survival time of implants and patients.
Read More
Green Consensus is the first web3 cannabis company operating from Switzerland. The goal of the company is to deliver a new framework for secure data collection related to cannabis health effects. The company was founded in 2019 and has already kickstarted 3 major initiatives.
Green Consensus and dHealth are working together to deliver a surveying infrastructure that will enable cannabis-related data collection which will then be fed into cutting-edge AI technology. This will allow the cannabis community to find new revolutionary discoveries related to cannabis health effects.
Read More
Swiss TPH is a leading institution in the fields of international and public health. Dedicated to advancing human well-being and improving health equity on a global scale, the institute conducts innovative research, offers top-tier educational programs, and provides comprehensive health services. Swiss TPH's overarching vision is a world where high-quality healthcare is accessible to all, regardless of geographic or socioeconomic conditions.
Swiss TPH and dHealth have collaborated on two use cases related to infectious diseases. The first use case developed was the utilization of dHealth’s blockchain to track the transport of rabies medication, as well as the recipient’s health status after inoculation. The second was related to COVID-19, and it was focused on tracking COVID-19 outbreaks.
Read More
The University of Zurich Blockchain Center serves as a hub of expertise and innovation in the fast-evolving world of blockchain technology. By fostering interdisciplinary research and promoting academic-industrial partnerships, the center aims to lead the way in blockchain applications across various sectors. With its commitment to rigorous scholarship and practical solutions, the University of Zurich Blockchain Center is not only advancing the field but also shaping the future of decentralized technologies.
The University of Zurich Blockchain Center used to run a Validator Node. The blockchain center also conducted research on the token migration during the network launch and the willingness of individuals and organizations to share data for incentives. UZH Blockchain Center used to run a Validator Node. The blockchain center also conducted research on the token migration during the network launch and the willingness of individuals and organizations to share data for incentives.
The European and Developing Countries Clinical Trials Partnership (EDCTP) stands at the forefront of accelerating medical research and innovation for diseases affecting the world's most vulnerable populations. With a strong focus on collaboration between European and developing countries, EDCTP acts as a catalyst for conducting clinical trials, supporting capacity-building, and facilitating regulatory approval processes.
The European and Developing Countries Clinical Trials Partnership (EDCTP) sponsored the Blockrabies project.
Eli Lilly is the 10th largest pharmaceutical company in the world by revenue, and it is headquartered in Indianapolis, USA. The healthcare giant has a particular focus on oncology, diabetes care, and neuroscience, and is a leading player in research and development. Eli Lilly has received numerous awards for its ethical standards and contributions to healthcare, solidifying its industry leadership.
Eli Lilly operates a validator node and functions as a multiplier of dHealth in their network.
Located in Pune, India, MIT-ADT University is a center for diverse academic programs ranging from engineering and arts to management. The institution emphasizes a balanced approach to education, integrating technological advancements and cultural enrichment. MIT-ADT University's innovative pedagogy has made it one of the top educational institutions in the region.
MIT-ADT was one of the key partners responsible for the realization of dHealth’s first Innovation Hub. Likewise, dHealth sponsored MIT-ADT students to build on the dHealth blockchain during two semesters in 2022. The University is also running a Validator Node, securing the dHealth network.
The RedCap Consortium is a collective of research organizations and institutions aimed at enhancing clinical and translational research through data management solutions. The consortium leverages a network of shared resources, expertise, and technology to standardize and streamline data collection across diverse research settings.
The dHealth Foundation is part of the RedCap Consortium which offers a secure web application for building and managing online surveys and databases. It is integrated with the Centiva Life Application.
Bowhead Health is a company specializing in secure healthcare data management and individualized wellness solutions. Using blockchain technology, Bowhead Health has developed platforms that allow patients to maintain control over their medical data while ensuring data security. Their solutions are in use across a range of medical and wellness applications.
The dHealth Foundation supports Bowhead Health in building decentralized monitoring tools for end-users by providing access to the dHealth network and expertise.
The University of Applied Sciences and Arts Northwestern Switzerland, commonly known as FHNW, is a multidisciplinary institution located in various cities across Switzerland. FHNW offers a wide range of undergraduate and postgraduate programs in fields such as engineering, business, and health sciences, making it a key contributor to Swiss higher education.
The FHNW University runs a Validator Node and frequently assigns researchers eager to study blockchain technology—to conduct research on the dHealth network.
HOPR is a blockchain-based organization committed to enhancing data protection and privacy on the internet. Through its decentralized protocols, HOPR offers individuals and enterprises solutions to secure their data transmissions and maintain their online privacy.
HOPR is operating a Validator Node.
Located in Gifu, Japan, Gifu University offers diverse academic programs and has extensive research facilities. Known for its faculties in medicine, engineering, and agriculture, the university engages in multidisciplinary research. Annually, it publishes over 2,000 research papers, contributing significantly to both regional and global scientific communities.
Gifu University operates a Validator Node and is testing the use of dHealth Network for storing data and tracking biosamples.
Located in Hanoi, the National Lung Hospital in Vietnam serves as a leading center for respiratory healthcare, handling over 20,000 patient visits annually. Specializing in the diagnosis and treatment of lung diseases, the hospital combines advanced technology and a team of highly skilled medical professionals to deliver exceptional care. With its multi-faceted approach to pulmonary health, the National Lung Hospital stands as a cornerstone of comprehensive respiratory treatment in the region.
The National Lung Hospital in Vietnam was the first to utilize DHP incentives to improve the health outcomes of patients. Patients received Digital Health Points when filling out questionnaires presented inside the app via the REDCap data collection tool. The project started in December 2019 and was halted shortly after due to the SARS-CoV-2 pandemic.
Read More
Headquartered in Basel, Switzerland, Novartis is a global healthcare giant that stands at the intersection of pioneering research and patient-focused solutions. With a presence in over 155 countries, Novartis is committed to leveraging innovative science to address some of the world’s most challenging healthcare issues. The healthcare giant’s main goal is to improve the quality of life for people across the globe.
Novartis and dHealth, together with the University of Basel and the Swiss TPH—partnered to develop a COVID-19 module that would assist with tracking and subduing SARS-CoV-2 outbreaks.
Read More